Supreme Court: Imminent Death Not Required For a Statement to Qualify as Dying Declaration  ||  SC: HC Cannot Grant Pre-Arrest Bail Without Quashing FIR; Accused Must Approach Sessions Court First  ||  SC: Agreed Interest Rate Cannot Be Challenged as Exorbitant; Arbitrator Cannot Override Contract  ||  SC: Agreed Interest Rate Cannot Be Challenged as Exorbitant; Arbitrator Cannot Override Contract  ||  SC: GST Exemption on Residential Lease Applies When Building is Sub-Leased for Hostel/PG Use  ||  Rajasthan High Court: Universities Cannot Retain Students’ Original Documents for Pending Fees  ||  NCLT: Damages from Contractual Disputes Cannot Form Basis for Initiating Insolvency Proceedings  ||  Del HC: Pre-SCN Consultation is Unnecessary in Large-Scale GST Fraud Cases with Complex Transactions  ||  Calcutta HC: Unilaterally Appointed Arbitrator Violates Natural Justice and Sets Aside the Award  ||  Raj HC Upholds Padmesh Mishra’s AAG Appointment, Noting Advocacy Skill isn’t Tied to Experience    

Search Results for Tag : diabetes

Notifications & Circulars

Dr. Jitendra Singh releases 'Indian Guidelines for Diabetes Management'(09.05.2018)

The Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances.....

Tags : Guidelines, Diabetes Management, Release



Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



News

Delhi HC Sets Aside Centre's Ban on FDCs for Type-2 Diabetes(18.02.2019)

Delhi High Court has set aside Centre's notifications banning manufacture and sale of fixed drug combinations (FDCs) used for treatment of Type-2 diab.....

Tags : Delhi High Court, FDCs for Type-2 Diabetes



Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin”(14.12.2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporatio.....

Tags : Kolkata Patent Office, Patent , Diabetes Drug Teneligliptin



Disclaimer | Copyright 2025 - All Rights Reserved